Movatterモバイル変換


[0]ホーム

URL:


US3877435A - Implanting method - Google Patents

Implanting method
Download PDF

Info

Publication number
US3877435A
US3877435AUS332019AUS33201973AUS3877435AUS 3877435 AUS3877435 AUS 3877435AUS 332019 AUS332019 AUS 332019AUS 33201973 AUS33201973 AUS 33201973AUS 3877435 AUS3877435 AUS 3877435A
Authority
US
United States
Prior art keywords
implant
valve
tubular organ
vas
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US332019A
Inventor
Louis Bucalo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Investors in Ventures Inc
Original Assignee
Investors in Ventures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Investors in Ventures IncfiledCriticalInvestors in Ventures Inc
Priority to US332019ApriorityCriticalpatent/US3877435A/en
Priority to US464637Aprioritypatent/US3880137A/en
Application grantedgrantedCritical
Publication of US3877435ApublicationCriticalpatent/US3877435A/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

A method for introducing a two-piece implant into a living being. A tubular organ such as a vas deferens is divided into a pair of separate portions having free ends adjacent each other. The implant has a pair of parts which are separately introduced into the lumens of the separate portions of the tubular organ while the parts of the implant remain accessible at the free ends of these separate portions of the tubular organ. These parts which are thus accessible are then joined together to render the implant operative without excessive stretching of the tubular organ so that excessive slack is not produced therein. The tubular organ may be a vas deferens while the implant is a vas valve capable of reversively blocking flow in the vas deferens and having the separate parts one of which is constituted by a tubular component and the other of which is constituted by the remainder of the vas valve, these parts being united after being introduced into the lumens to provide the assembled vas valve.

Description

United States Patent [191 Bucalo IMPLANTING METHOD [75] Inventor: Louis Bucalo, Holbrook, N.Y.
[73] Assignee: Investors In Ventures, Inc., New
York, NY.
[22] Filed: Feb. 12, 1973 [21] Appl. No.: 332,019
[52] U.S. Cl 128/334 C [51] Int. Cl A61b 17/11 [58] Field of Search ..128/1 R, 303 R, 334 R; 334 C, 128/348 [56] References Cited UNITED STATES PATENTS 2,638,901 5/1953 Sugarbaker 128/334C 3,030,953 4/1962 Koehn 128/214.4
3,704,704 12/1972 Gonzales 128/1 R Primary Examiner-Da1ton L. Truluck Attorney, Agent, or FirmSteinberg & Blake [451 Apr. 15, 1975 [57] ABSTRACT A method for introducing a two-piece implant into a living being. A tubular organ such as a vas deferens is divided into a pair of separate portions having free ends adjacent each other. The implant has a pair of parts which are separately introduced into the lumens of the separate portions of the tubular organ while the parts of the implant remain accessible at the free ends of these separate portions of the tubular organ. These parts which are thus accessible are then joined together to render the implant operative without excessive stretching of the tubular organ so that excessive slackis not produced therein. The tubular organ may be a vas deferens while the implant is a vas valve capable of reversively blocking flow in the vas deferens and having the separate parts one of which is constituted by a tubular component and the other of which is constituted by the remainder of the vas valve, these parts being united after being introduced into the lumens to provide the assembled vas valve.
2 Claims, 10 Drawing Figures 52 I54 ,2 /0\ ,8 1.. i 1* i 56 T ///,l (//1/1/ E X/V/ /l// IMPLANTING METHOD BACKGROUND OF THE INVENTION The present invention relates to methods for introducing implants for living beings.
In particular, the present invention relates to methods for introducing implants which are designed to be received in the lumens of tubular organs.
When an implant such as a vas valve is to be introduced into the lumen of a tubular organ such as a vas deferens, it is customary to divide the tubular organ such as the vas deferens into a pair of separate portions which have free ends adjacent to each other. The surgeon will then introduce the implant, such as a vas valve, first into the lumen of one of the separate portions of the tubular organ and then into the lumen of the other of the separate portions of the tubular organ. Because the parts of the implant which are respectively received in these lumens of the separate portions of the tubular organ are relatively long, it is necessary for the surgeon to stretch the tubular organ and distend it to an undesirable extent in order to be able to effectively introduce the implant into the lumens of the separate portions of the tubular organ. The result of these procedures is that a considerable amount of slack is introduced into the tubular organ resulting sometimes in prevention of reestablishment of flow when an implant such as a valve is placed in its open position.
A further problem which is encountered with an implant which is in the form of a valve is that it is sometimes difficult for the physician to know from the exterior ofthe valve when it is in its open position and when it is in its closed position.
In addition, when the implant is a valve, it sometimes happens that the openings at the opposed free ends of the valve become blocked by substances situated in the lumen of the vas deferens or the like, so that even when the valve is open to reestablish flow through the tubular organ, such flow cannot be reliably established.
In this latter connection, it sometimes happens that even during introduction of the implant into the lumen, substances in the lumen itself flow into the interior of the implant blocking the interior of the implant and preventing flow therethrough in an desirable manner.
SUMMARY OF THE INVENTION It is accordingly a primary object of the present invention to provide an implant and implanting method which will avoid the above drawbacks.
In particular, it is an object of the present invention to provide an implant and implanting method which will avoid the necessity of excessive distension of the tubular organ during introduction of the implant into the lumen thereof.
A more specific object of the present invention is to provide an implanting method involving a vas valve which can be introduced into a tubular organ formed by a vas deferens in such a way that excessive distension of the latter will not be required.
It is also an object of the present invention to provide an implanting method which enables a vas valve to be introduced into the vas deferens in a manner which will avoid blocking of the interior of the valve.
According to the method of the invention, the tubular organ which is to receive the implant is cut through so as to form a pair of portions having free ends situated adjacent each other, and then a two-part implant has its respective parts introduced separately into the lumens of the separate portions of the tubular organ with the two parts of the implant accessible at the free ends of these separate portions. These separate parts of the implant are then joined to each other so as to render the implant operative and so as to complete the assembly thereof, and through this expedient it becomes possible to introduce the implant without excessive distension of the tubular organ.
BRIEF DESCRIPTION OF DRAWINGS The invention is illustrated by way of example in the accompanying drawings which form part of this application and in which:
FIG. 1 is a longitudinal sectional elevation schematically illustrating a vas deferens with an implant of the invention situated therein;
FIG. 2 is an end view of the vas valve of FIG. 1 as seen from the right of FIG. 1;
FIG. 3 is a fragmentary sectional elevation illustrating the connecting means carried by the separate components of the vas valve for connecting them to each other;
FIG. 4 is a fragmentary side elevation of one end region of the vas valve, the other end region having the same construction;
FIG. 5 is a transverse sectional elevation of the structure of FIG. 4 taken along line 55 of FIG. 4 in the direction of the arrows;
FIG. 6 is a schematic illustration of the method of the present invention for introducing an implant into a tubular organ;
FIG. 7 shows in elevation a mandrel to be used with one of the components of FIG. 1;
FIG. 8 is an illustration of another mandrel to be used with the other of the components of the vas valve of FIG. 1;
FIG. 9 is a fragmentary side elevation of one end of the vas valve of FIG. 1 showing a further addition thereto; and
FIG. 10 is a transverse section of the structure of FIG. 9 taken along line l0-10 of FIG. 9 in the direction of the arrows.
DESCRIPTION OF PREFERRED EMBODIMENTS Referring to FIG. 1, theimplant 10 of the invention is in the form of a vas valve in the illustrated example. This valve includes a pair ofparts 12 and 14. Thepart 12 is in the form of an elongated tube made of any suitable material which is compatible with the body, while thepart 14 includes therest of the vas valve. Thus, thepart 14 includes thevalve housing 16 carrying in its interior the rotary valve member whose stem is connected to theturnable element 18 at the exterior of the valve. Thiselement 18 is turned for the purpose of opening and closing the valve. In addition, thepart 14 includes thetubular element 20 which is integral with and extends to the right from thehousing 16, as illustrated in FIG. 1. Thistubular part 20 may be located at the teste side of the valve while thepart 12 may be located at the urethral side.
Thetubular part 12 is formed at the region of its free end which is distant from thepart 14 with a longitudinally extendingslot 22 extending completely across thetubular part 12 inwardly from the left free end thereof, as viewed in FIG. 1, through the distance indicated in FIG. 1. In the same way, thetubular part 20 is formed with anelongated slit 24 extending completely across thepart 20 and inwardly from the right free end thereof through a distance such as that indicated at the right in FIG. 1.
In addition, thepart 12 terminates at its right end in abarrier flange 26 formed, as shown in FIG. 2, with fourperipheral Vnotches 28 displaced by 90 with respect to each other about the periphery of theflange 26 so as to promote the ingrowth of tissue into these notches and thus provide a secure lodging of thepart 12 in the vas deferens which forms the tubular organ in the illustrated example. In addition, theflange 26 is formed with a series ofopenings 28 through which tissue may grow.
A means is provided for fastening theparts 12 and 14 to each other after they are respectively introduced into the lumens of the separate portions of vas deferens which are illustrated in FIG. 1. Thus, before the implant is situated in the tubular organ, this organ is transversely cut through so as to be divided into a pair of separate portions. Thus it will be seen that the vas deferens illustrated in FIG. 1 includes the elongatedleft portion 30 and the elongatedright portion 32, these portions respectively terminating in thefree ends 34 and 36 which are adjacent each other. As may be seen from FIG. 6., after the vas deferens illustrated has been cut through, itsseparate portions 30 and 32 need only be deflected to an extremely small extent so as to be capable of receiving the implant of the invention. Thepart 30 which is angularly positioned approximately as shown in FIG. 6 will separately receive thetubular part 12 of the vas valve, this part being first covered at its exterior with a filamentary material such asgold wire 38. This wire may be wound around the exterior of thetubular part 12 and may also take the form of a suitable braid. Thus, by way of the use of this filamentary material it is possible to promote the ingrowth of tissue into intimate contact with the exterior surface of thetubular part 12, so as to greatly reduce the possibility of travel of sperm along the exterior of thetubular component 12.
In the same way, with theseparate portion 32 of the vas deferens situated somewhat illustrated in FIG. 6, it is possible for the surgeon to introduce theother part 14 into the lumen of theseparate portion 32. Thispart 14 also carries at the exterior of the tubular extension thefilamentary material 40 in the form of gold wire or braid which covers the exterior surface of thetubular portion 20, and it will be noted that this material is extended all the way up to the part of thehousing 16 which engages the vas deferens, and the braid orwire 38 also extends all the way up to the part of theflange 26 which engages the vas deferens. Thus the ingrowth of tissue will also be promoted into intimate contact with the exterior surface of thepart 20 and the part of thehousing 16 adjacent to thepart 20 in order to reduce the possibility of travel of sperm along the exterior of thepart 14.
Theseparts 12 and 14 of the implant carry ameans 42 for interconnecting these parts with each other after they have been introduced into the lumens of the separate portions and 32 of the tubular organ. Thisconnecting means 42 is shown in detail in FIG. 3. Thus in accordance with the illustrated example thetubular part 12 has at the region of the flange 26 afemale component 44 which is hollow and tapered at its interior, while thepart 14 has amating male component 46 which has at its exterior a taper which matches that of the interior of thefemale component 44. Thus, with this construction after the two parts of the valve are respectively received in the lumens of theseparate portions 30 and 32, themale component 46 and thefemale component 44 of the connectingmeans 42 are joined together with themale part 46 received with a tight wedge fit in thefemale part 44, so that in this way the valve is rendered operative.
As a result of this feature the extent to which the tubular organ must be distended is greatly reduced so that there is very little if any slack which will produce undesired curvature of the tubular organ preventing in some cases the desired reestablishment of flow through the tubular organ. Thus, by dividing the implant into two parts which are joined to each other after the parts are respectively received in the lumens of the separate portions of the tubular organ, it is possible to join these parts together in such a way that the extent to which the tubular organ must be stretched and displaced from its initial location is very greatly reduced.
According to a further feature of the invention, prior to introducing thepart 12 into the lumen of theportion 30 of the vas deferens, the mandrel 48 shown in FIG. 7 is situated in the interior of and fills the longitudinal bore of thepart 12 so that this bore will not become blocked by or receive any of the material within theportion 30 of the vas deferens. In the same way asecond mandrel 50 is situated in and completely fills thetubular part 20 at the bore of the latter so that this bore cannot become blocked during introduction of thepart 14 into the lumen of theseparate portion 32 of the vas deferens. For this purpose it is to be noted that thepart 18 is turned so as to situate the valve in its open position, and themandrel 50 is long enough to extend through the bore of the rotary valve member as well as through themale part 46 of the connecting means and of course through the entire length of thetube 20 all the way up to the right end of the latter.
In this connection it is to be noted that after completion of the implanting procedures even if it should happen that the free ends of thetubular part 12 and 20 which are distant from each other become blocked, it will nevertheless be possible for the semen and other fluids to enter into the bores of thetubular parts 12 and 20 through theslots 22. Thus, after the implant has been introduced into the tubular organ, the valve will, after a certain period of time, be turned to its closed position. For this purpose therotary part 18 carries across pin 52 received in suitable slots of arotary wrench 54 shown in phantom lines in FIG. 1. Thepart 18 fixedly carries aspringy detent 56 capable of being received either in the recess 58, at the periphery of an upper flange of thehousing 16, when the valve is in its open position as illustrated, or in adetent recess 60 displaced from the recess 58. When thespringy detent 56 is in therecess 60 the valve is closed. Thus by providing these detent recesses and thespringy detent member 56 it is possible for the operator to reliably locate the valve either in its open or closed position without any difficulty.
It will be noted from FIGS. 7 and 8 that themandrels 48 and 50 are respectively provided with handles 62 and 64. After thepart 12 has been situated within the lumen of theseparate portion 30 of the vas deferens, the mandrel 48 is removed, and the handle 62 is provided to facilitate the introduction and removal of the mandrel 48 from thetubular part 12. In the same way, after thepart 14 has been received in the lumen of theseparate portion 32 of the vas deferens, themandrel 50 is removed, and the handle 64 facilitates the introduction and removal of themandrel 50 from thepart 14.
It is to be noted that theslots 22 and 24 may be replaced by a series oflateral openings 66 illustrated in FIGS. 4 and 5. Thus, instead of longitudinally extending slots as illustrated in FIG. 1, it is possible to provide the free ends of the valve each with a plurality ofopenings 66 as shown in FIGS. 4 and 5 at the free end of thetubular part 20, and thus with this construction also if it should happen that the free end of the tubular extension becomes blocked nevertheless it will be possible for fluid to enter through thelateral openings 66. Thus, this construction of FIGS. 4 and 5 is also included at the left end portion of thepart 12 instead of theslot 22, if desired. Therefore, either with theslots 22 and 24 or with thelateral openings 66 it is possible when the valve is placed in its open position to reestablish flow through the tubular organ in a highly reliable manner even if it should happen that the free ends of the tubular organ become blocked.
Thus, the vas valve will initially remain in its open position until a sufficient time has elapsed for the implant to become properly lodged in the tubular organ with ingrowth of tissue occurring and with no possible build up of pressure within the tubular organ. Then the valve may be placed in its closed position so as to block the flow, and thus reliably prevent conception. In this connection it is to be noted that the ingrowth of tissue at the filamentary material at the exterior of the valve greatly cuts down any possibility of travel of sperm along the exterior of the valve. This prevention of travel of sperm along the exterior of the valve is greatly enhanced by the presence of thebarrier 26. However, if it should be desired at any future time to reestablish the flow of fluid through the vas deferens, the valve can be returned to its open position, and then by reason of theslots 22 and 24 or the openings 66 a reliable reestablishment of flow is assured. Furthermore, because of the minimal distension of the tubular organ during the introduction of the implant, according to the method of the invention, utilizing a two-part implant which has its parts connected to each other after they are received in the tubular organ, as described above, there is no possibility of formation of loops or other undesirable configurations in the tubular organ resulting from undesirable slack therein, so that in this way also a reestablishment of flow is assured and the possibility of undesirable growths or the like which could result from such slack is also reliably avoided.
In order to further prevent blocking of the interior of the vas valve. further measures are taken in accordance with further features of the invention.
Thus, upon cutting through the vas to provide the separatedportions 30 and 32 shown in FIG. 6, it will be found that lumen is covered with a layer of mucosa. In accordance with a further feature of the present invention a suitable reamer which is not illustrated is introduced into the lumen of theportion 30 of the vas so as to remove from the inner surface the lining of mucosa at least through a length equal to that which will subsequently be occupied by the left portion of the valve as illustrated in FIG. I. The same operations are then performed with theright portion 32 of the vas deferens so that in the latter also the inner lining of mucosa is removed at least through a length sufficient to accommodate the right portion of the valve as illustrated in FIG. 1. Thus, through this expedient of reaming out the mucosa linings along the lumen portions where the vas valve is to be accommodated there is a considerable reduction of possibility of blocking the valve passages during introduction of the valve into the lumen of the vas.
Furthermore, as is illustrated in FIGS. 4 and 5, the exterior surfaces of the valve at the region of its opposed ends is provided with a coating ofplastic 70. Thus, FIGS. 4 and 5 illustrate that embodiment where the opposed ends are provided with thelateral openings 66 as described above, but the plastic coating of FIGS. 4 and 5 can also be utilized with the embodiment of FIG. 1 where the opposed ends of the valve are provided with theslots 22 and 24. In the case of FIGS. 4 and 5 theopenings 66 are not covered by theplastic layer 70, and of course with the embodiment of FIG. 1 theslots 22 and 24 also would not be covered by the plastic coating. Thisplastic coating 70 which is deposited in any suitable way on the exterior surface of the valve at its opposed end regions as illustrated in FIGS. 4 and 5 has the property of bonding itself intimately to the exterior surface of the valve so that it will remain securely connected thereto, and in addition the plastic coating will prevent the vas from adhering at its lumen to the exterior surface of the valve at the end regions thereof which are provided with theplastic coating 70. This plastic coating may be made of any plastic which will not adhere to the inner surface of the vas deferens. For example Teflon may be used for theplastic layer 70 which will prevent the vas from adhering to the outer end regions of the valve so that in this way there is an assurance that theopenings 66 will remain free and clear to function properly whenever it is desired to reestablish fluid flow. Of course the same results will be achieved when the plastic coating is provided with the embodiment of FIG. 1. While Teflon has been mentioned above, it is of course possible to use any other plastic which is compatible with the human body and which has the property of preventing the vas from adhering to the surface of the plastic.
A further expedient for achieving results similar to those achieved with the embodiment of FIGS. 4 and 5 is illustrated in FIGS. 9 and 10. Thus, referring to FIGS. 9 and 10 it will be seen that the end of the valve which has theslot 24 has deposited thereon elongated andcircumferential beads 72. Thesebeads 72 are made of a metal which is different from the metal used for the valve. The longitudinal andcircumferential beads 72 are deposited in any suitable way on the elongated free end portion of the valve which is provided with theslot 24 shown in FIGS. 9 and 10, and of course the opposed elongated end region of the valve which is provided withslot 22 is also provided with these beads ofmetal 72. The beads ofmetal 72 are made of any metal which is different from the metal used for the valve. For example if the elongated end regions of the valve are made of gold, then thebeads 72 may be made of platinum or nickel.
Of course, this deposition of beads of a dissimilar metal on the exterior surface of the end regions of the valve can also be used with the embodiment of FIGS. 4 and 5, in which case the beads will not close any of theopenings 66. It will be noted that the beads do not close theslots 22 or 24.
As a result of the presence of the dissimilar metals there is an automatic generation of microvoltages which have the effect also of preventing adherence of the vas to the regions of the valve where the dissimilar metals are located. Therefore by depositing on the end regions of thevalve beads 72 of a metal different from the metal on which the beads are deposited there is an automatic creation of microvoltages which will reliably prevent adhering of the vas to the end regions of the valve. it is to be noted that thebeads 72 are shown at a considerable distance from each other in FIGS. 9 and 10 for the sake of clarity. Actually the network of longitudinal and circumferential beads will be denser than illustrated in FIGS. 9 and 10.
Therefore, by way of these expedients it is possible on the one hand to prevent the vas from adhering to the end regions of the valve and on the other hand by reaming out the interior mucosa linings initial blocking of the valve during introduction of the latter into the lumen is also reliably prevented.
What is claimed is:
1. In a method for introducing an implant into a tubular organ of a living being, the steps of cutting transversely through the tubular organ to divide the latter into a pair of separate portions respectively having free ends located adjacent each other, introducing one part of an implant into the lumen of one of the separate portions of the tubular organ through the free end of the latter while maintaining said one part of said implant accessible at the latter free end, introducing another part of the implant into the lumen of the other of the separate portions of the tubular organ through the free end of the latter while maintaining said other part of said implant accessible at the latter free end, and then 10 joining the parts of the implant directly to each other without any space therebetween, so that the entire implant is'introduced into the lumens of the separate portions of the tubular organ without excessive stretching and displacement of the tubular organ during introduction of the implant into the latter, the'tubular organ being a vas deferens and the implant being a valve, and including the steps of removing inner mucosa linings from the lumens of the separate portions of the vas deferens prior to introduction of the valve parts into the lumens so as to reduce the possibility of blocking valve passages during introduction of the valve parts into the lumen.
2. In a method as recited in claim 1 and wherein the mucosa linings are removed by reaming operations.

Claims (2)

1. In a method for introducing an implant into a tubular organ of a living being, the steps of cutting transversely through the tubular organ to divide the latter into a pair of separate portions respectively having free ends located adjacent each other, introducing one part of an implant into the lumen of one of the separate portions of the tubular organ through the free end of the latter while maintaining said one part of said implant accessible at the latter free end, introducing another part of the implant into the lumen of the other of the separate portions of the tubular organ through the free end of the latter whilE maintaining said other part of said implant accessible at the latter free end, and then joining the parts of the implant directly to each other without any space therebetween, so that the entire implant is introduced into the lumens of the separate portions of the tubular organ without excessive stretching and displacement of the tubular organ during introduction of the implant into the latter, the tubular organ being a vas deferens and the implant being a valve, and including the steps of removing inner mucosa linings from the lumens of the separate portions of the vas deferens prior to introduction of the valve parts into the lumens so as to reduce the possibility of blocking valve passages during introduction of the valve parts into the lumen.
US332019A1973-02-121973-02-12Implanting methodExpired - LifetimeUS3877435A (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
US332019AUS3877435A (en)1973-02-121973-02-12Implanting method
US464637AUS3880137A (en)1973-02-121974-04-26Two-piece implants

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US332019AUS3877435A (en)1973-02-121973-02-12Implanting method

Publications (1)

Publication NumberPublication Date
US3877435Atrue US3877435A (en)1975-04-15

Family

ID=23296368

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US332019AExpired - LifetimeUS3877435A (en)1973-02-121973-02-12Implanting method

Country Status (1)

CountryLink
US (1)US3877435A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3990434A (en)*1975-02-181976-11-09The United States Of America As Represented By The Department Of Health, Education And WelfareReversible intravasal occlusive device
US4607637A (en)*1983-07-221986-08-26Anders BerggrenSurgical instrument for performing anastomosis with the aid of ring-like fastening elements and the fastening elements for performing anastomosis
US4624257A (en)*1982-06-241986-11-25Anders BerggrenSurgical instrument for performing anastomosis
US5636627A (en)*1991-04-121997-06-10N.J. Rochester LimitedEquipment and method for gas extraction in general anaesthesia
US20070239180A1 (en)*2006-04-062007-10-11Synovis Life Technologies, Inc.Method and assembly for anastomosis
US20090069827A1 (en)*2007-09-072009-03-12The Penn State Research FoundationReversible vasectomy device and method

Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2638901A (en)*1951-07-301953-05-19Everett D SugarbakerSurgical clamp
US3030953A (en)*1957-10-171962-04-24Wilbur R KoehnApparatus for applying catheter
US3704704A (en)*1970-10-121972-12-05Ramon L GonzalesBirth control valve

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2638901A (en)*1951-07-301953-05-19Everett D SugarbakerSurgical clamp
US3030953A (en)*1957-10-171962-04-24Wilbur R KoehnApparatus for applying catheter
US3704704A (en)*1970-10-121972-12-05Ramon L GonzalesBirth control valve

Cited By (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3990434A (en)*1975-02-181976-11-09The United States Of America As Represented By The Department Of Health, Education And WelfareReversible intravasal occlusive device
US4624257A (en)*1982-06-241986-11-25Anders BerggrenSurgical instrument for performing anastomosis
US4917090A (en)*1982-06-241990-04-17Unilink, Inc.Method for performing an anastomosis
US4607637A (en)*1983-07-221986-08-26Anders BerggrenSurgical instrument for performing anastomosis with the aid of ring-like fastening elements and the fastening elements for performing anastomosis
US5636627A (en)*1991-04-121997-06-10N.J. Rochester LimitedEquipment and method for gas extraction in general anaesthesia
US20070239180A1 (en)*2006-04-062007-10-11Synovis Life Technologies, Inc.Method and assembly for anastomosis
US8313013B2 (en)2006-04-062012-11-20Synovis Life Technologies, Inc.Method and assembly for anastomosis
US20090069827A1 (en)*2007-09-072009-03-12The Penn State Research FoundationReversible vasectomy device and method
US8161973B2 (en)2007-09-072012-04-24The Penn State Research FoundationReversible vasectomy device and method

Similar Documents

PublicationPublication DateTitle
KR100385258B1 (en) Artificial blood vessel
US5049154A (en)Adjustable intra-luminal valvulotome
US11589899B2 (en)Artificial insemination system and method of use
US3648683A (en)Reversible intra-vas device
US3815578A (en)Method of inserting an implant into a portion of a tubular organ whose mucous lining has been partially removed
CA1066456A (en)Vascular insert and process for making it
US3828764A (en)Non-migrating reversible make sterilization coupler
US3938528A (en)Implanting and splicing articles and methods for living beings
US2835253A (en)Surgical appliance
US5820631A (en)Device and method for suturing tissue adjacent to a blood vessel
US20130144331A1 (en)Introducer sheath
JPH0354729Y2 (en)
EP3977961B1 (en)Vascular reconstruction device
EP1356787A1 (en)Catheter for repair of endoluminal grafts
US3880137A (en)Two-piece implants
US3938499A (en)Implant and implanting method and tool
EP0593600A1 (en)Tubular surgical implant
US3877435A (en)Implanting method
JP2003534034A (en) Apparatus and method for endoscopic vascular surgery
US20030114923A1 (en)Graft and method of making
JP7410990B2 (en) In-vivo indwelling tube
WO2020033625A1 (en)Artificial insemination system
JPH05502814A (en) adjustable endoluminal valve dissector
US20230285018A1 (en)Closing device for tissue openings
JP5936093B2 (en) Double lumen dilator

[8]ページ先頭

©2009-2025 Movatter.jp